Clinical Trial Update: Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update examining when to start liraglutide therapy in patients with obesity after metabolic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Obesity, Weight Loss | Phase 4 | Status: COMPLETED